Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Curative-Intent Metastasis-Directed Therapies for Molecularly-Defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis HypothesisEur Urol 2021 Mar 05;[EPub Ahead of Print], RM Glicksman, U Metser, D Vines, J Valliant, Z Liu, PW Chung, RG Bristow, A Finelli, R Hamilton, NE Fleshner, N Perlis, AR Zlotta, D Green, A Bayley, J Helou, S Raman, G Kulkarni, C Catton, T Lam, R Chan, P Warde, M Gospodarowicz, DA Jaffray, A Berlin
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.